A membrane-free dialysis microfluidic control chip
Through the design of the membrane-free dialysis microfluidic control chip, the cell-free layer is formed by using the reflective column and the arc-shaped working pipeline is optimized, which solves the problems of dialysis membrane rejection and blood cell loss, and achieves efficient blood purification and dialysis efficiency improvement.
Patent Information
- Application Number
- CN202111218510.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2021-10-20
- Publication Date
- 2024-11-08
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
The dialysis membrane in existing dialysis devices has problems with rejection, blood transport disorders and membrane contamination, resulting in low dialysis efficiency and large blood cell losses.
Design a membrane-free dialysis microfluidic control chip, adopting membrane-free dialysis technology, by placing reflective columns in the middle of the working pipeline, using the F-L effect to form a cell-free layer, to realize the purification process of transferring small molecules in the blood into the dialysate. And reduce the spacing between reflective columns in the arc-shaped working pipe to prevent cell loss.
The dialysis chip structure is simplified, the rejection reaction is reduced, the dialysis efficiency is improved, the blood cell loss is reduced, the membrane pollution is avoided, and the blood purification effect is improved.
Smart Images

Figure CN113855886B_ABST
Abstract
Description
Technical Field
[0001] The embodiments of the present invention relate to the field of membraneless dialysis technology, and in particular to a membraneless dialysis microfluidic control chip. Background Art
[0002] At present, there are nearly 800,000 dialysis patients in my country. With the accelerated progress of aging in my country, the continuous improvement of dialysis quality and dialysis treatment rate, and the improvement and perfection of medical insurance, the number of dialysis patients has continued to grow at a rate of about 10% per year. It is estimated that the number of patients requiring dialysis treatment will exceed 3 million in 2030. Dialysis is one of the effective measures to prolong the life of patients and improve the quality of life of terminal patients. The hemodialysis machine, commonly known as the "artificial kidney", is an extracorporeal hemodialysis device that can replace part of the kidney function, remove harmful substances from the blood, correct electrolytes in the body and maintain acid-base balance. Portable dialysis devices (or artificial kidneys) can be carried with you and can become a part of the patient's body like a pacemaker, serving as an auxiliary device for the patient to continue his life. The development and improvement of artificial kidney microfluidic chips is one of the bottleneck issues of artificial kidneys.
[0003] Most of the existing dialysis devices are membrane dialysis, and the dialysis effect depends on the physical and chemical properties of the dialysis membrane. There are three types of dialysis membranes commonly used in clinical practice: regenerated cellulose membrane, modified cellulose membrane, and synthetic polymer membrane. They all have good biocompatibility, can have a high clearance rate for solutes, and can prevent the passage of "large molecules" such as red blood cells and proteins in the blood flow and bacteria and viruses in the dialysate.
[0004] However, there are still some problems with the use of dialysis membranes. First, all dialysis membranes have more or less "rejection", and the surface of the dialysis membrane will react non-physiologically with the cells and plasma components of the blood. Secondly, the blood layer in direct contact with the dialysis membrane is stationary relative to the dialysis membrane. Once this layer of blood is exchanged with the dialysis membrane, it becomes an obstacle to the subsequent blood transport exchange, making the transport more difficult and slow. Finally, the membrane surface will cause membrane contamination after a period of use. During the entire treatment period, the dialysis membrane interface remains in a fixed position, and any material attached to the interface tends to remain unchanged. Over time, the surface will be contaminated and its effectiveness will decrease. Summary of the invention
[0005] In order to solve the defects in the prior art, the present invention provides a membraneless dialysis microfluidic control chip to solve the problems of low efficiency and large cell loss in the prior dialysis, effectively increase the dialysis efficiency and reduce the loss of blood cells.
[0006] In a first aspect, an embodiment of the present invention provides a membraneless dialysis microfluidic control chip, comprising:
[0007] Blood inlet, dialysate inlet, straight working channel, reflection column, curved working channel, chip housing, blood outlet and dialysate outlet;
[0008] The blood inlet, the dialysate inlet, the straight working channel, the reflective column, the arc-shaped working channel, the blood outlet and the dialysate outlet are all installed in the chip housing;
[0009] The blood inlet and the dialysate inlet are symmetrically installed at the inlet of the straight working flow channel;
[0010] The blood outlet and the dialysate outlet are symmetrically installed at the outlet of the straight working flow channel;
[0011] The straight working flow channel and the arc-shaped working flow channel are tangentially connected;
[0012] The reflective columns are respectively arranged in the straight working flow channel and in the arc-shaped working flow channel.
[0013] Optionally, a plurality of the reflective columns are sequentially arranged along the path formed by the straight working channel and the curved working channel, and the radial distance from the center of each reflective column arranged in the straight working channel to the two sides of the straight working channel is the same, and the radial distance from the center of each reflective column arranged in the curved working channel to the two sides of the curved working channel is the same.
[0014] Optionally, the reflective column has a diameter of 50-100 μm and a height of 200 μm; in the straight working channel, the spacing between the reflective columns is 200-500 μm; in the curved working channel, the spacing between the reflective columns is 150-300 μm.
[0015] Optionally, an angle between the blood inlet and the dialysate inlet, and an angle between the blood outlet and the dialysate outlet are both 5°-30°.
[0016] Optionally, the straight working channel has a width of 400-600 μm and a height of 200 μm.
[0017] Optionally, the curvature radius of the arc-shaped working channel is 500-700 μm, the width is 400-600 μm, and the height is 200 μm. The advantages of the present invention compared with the prior art are:
[0018] (1) The present invention utilizes membraneless dialysis, which simplifies the structure of the dialysis chip and reduces rejection reactions. In addition, since there is no membrane, molecular aggregation and blockage will not occur, thereby improving dialysis efficiency.
[0019] (2) The present invention places a reflective column in the middle of the working pipe and utilizes the FL effect (Fhrus-Lindqvist effect) to form a cell-free layer around the reflective column. The cell-free layer contacts the dialysate and transfers small molecules in the blood to the dialysate to achieve the purpose of "purifying" the blood.
[0020] (3) The present invention reduces the spacing between the reflective columns in the arc-shaped working pipe, thereby preventing blood cells from drifting laterally under the action of the Dean flow, thereby preventing cell loss. BRIEF DESCRIPTION OF THE DRAWINGS
[0021] Figure 1 A top view of a membraneless dialysis microfluidic chip provided by an embodiment of the present invention;
[0022] Figure 2 A membraneless dialysis principle diagram of a membraneless dialysis microfluidic chip provided in an embodiment of the present invention.
[0023] In the figure: 1. blood inlet, 2. dialysate inlet, 3. straight working flow channel, 4. reflection column, 5. curved working flow channel, 6. chip housing, 7. blood outlet, 8. dialysate outlet. DETAILED DESCRIPTION
[0024] The present invention will be further described in detail below in conjunction with the accompanying drawings and embodiments. It is to be understood that the specific embodiments described herein are only used to explain the present invention, rather than to limit the present invention. It should also be noted that, for ease of description, only parts related to the present invention, rather than all structures, are shown in the accompanying drawings.
[0025] Example
[0026] See also Figure 1-2 An embodiment of the present invention provides a membraneless dialysis microfluidic control chip, including: a blood inlet 1, a dialysate inlet 2, a straight working channel 3, a reflection column 4, an arc-shaped working channel 5, a chip housing 6, a blood outlet 7 and a dialysate outlet 8.
[0027] Among them, the blood inlet 1, the dialysate inlet 2, the straight working channel 3, the reflection column 4, the curved working channel 5, the blood outlet 7 and the dialysate outlet 8 are all installed in the chip housing 6; the blood inlet 1 and the dialysate inlet 2 are symmetrically installed at the inlet of the straight working channel 3; the blood outlet 7 and the dialysate outlet 8 are symmetrically installed at the outlet of the straight working channel 3; the straight working channel 3 and the curved working channel 5 are tangentially connected; the reflection column 4 is respectively arranged in the straight working channel 3 and the curved working channel 5.
[0028] Among them, the chip shell 6 is 50mm long and 10-20mm wide; the setting angle between the blood inlet 1 and the dialysate inlet 2, and the setting angle between the blood outlet 7 and the dialysate outlet 8 are all 5°-30°; the width of the blood inlet 1, the dialysate inlet 2, the blood outlet 7 and the dialysate outlet 8 are all 300-500μm, and the height is 200μm; the width of the straight working channel 3 is 400-600μm, and the height is 200μm; the curvature radius of the arc working channel 5 is 500-700μm, the width is 400-600μm, and the height is 200μm.
[0029] Specifically, multiple reflection columns 4 are arranged in sequence along the path formed by the straight working channel 3 and the curved working channel 5, and the radial distance from the center of each reflection column 4 arranged in the straight working channel 3 to the two sides of the straight working channel 3 is the same, and the radial distance from the center of each reflection column 4 arranged in the curved working channel 5 to the two sides of the curved working channel 5 is the same.
[0030] like Figure 2 As shown, by placing a reflective column 4 in the middle of the working pipe, blood and dialysate flow through the two sides of the reflective column 4 respectively, and utilizing the FL effect (Fhrus-Lindqvist effect), a cell-free layer is formed around the reflective column 4. The cell-free layer is in contact with the dialysate, and small molecular harmful substances in the blood are transferred to the dialysate and taken away, thereby achieving the purpose of "purifying" the blood.
[0031] Furthermore, in this embodiment, the spacing between the reflective columns 4 in the curved working channel 5 is smaller than that in the straight working channel 3, so as to prevent the cell from flowing sideways under the action of the Dean flow, thereby causing cell loss. Specifically, in the straight working channel 3, the spacing between the reflective columns 4 is 200-500 μm; in the curved working channel 5, the spacing between the reflective columns 4 is 150-300 μm. Generally, the diameter of the reflective columns 4 is 50-100 μm and the height is 200 μm.
[0032] The embodiment of the present invention also provides a workflow of a membraneless dialysis microfluidic control chip, comprising the following steps:
[0033] Blood enters from the blood inlet 1, and dialysate enters from the dialysate inlet 2. Before entering the straight working channel 3, the two liquids are blocked by the reflection column 4 at the entrance, so that they flow on both sides of the straight working channel 3; in the straight working channel 3 and the curved working channel 5, the blood and the dialysate flow in parallel in the microchannel. On the contact surface, the mass diffusion coefficient of harmful components such as small molecules of viruses is greater than the mass diffusion coefficient of large molecules such as proteins and cells. As the blood and dialysate flow in parallel, the contact time between the two increases, and the small molecules of harmful components in the blood diffuse into the dialysate, so that the blood is purified. In addition, during the flow process, blood flows through the reflective column 4. The shear gradient and wall effect lift caused by the reflective column 4 will push the cells away from the column surface, so that the part of the blood in contact with the dialysate does not contain macromolecules such as blood cells and proteins, and only small molecules of harmful substances are transferred to the dialysate and taken away. Compared with the dialysis method in which the blood is directly in contact with the dialysate, the loss of useful components in the blood is reduced; during the flow of the arc-shaped working channel 5, in order to prevent the cells from drifting laterally into the dialysate under the action of the Dean flow and causing cell loss, the spacing of the reflective column 4 in the arc-shaped channel 5 is reduced; and then after passing through several straight working channels 3 and the arc-shaped working channel 5, the blood and the dialysate flow out from the blood outlet 7 and the dialysate outlet 8 respectively, completing the blood purification process. The embodiment of the present invention uses membraneless dialysis, simplifies the structure of the dialysis chip, reduces the rejection reaction, and because there is no membrane, molecular aggregation and blockage will not occur, thereby improving the dialysis efficiency.
[0034] Based on the above embodiments, multiple Figure 1 The membraneless dialysis microfluidic chips shown are used in series to further enhance the blood purification effect.
[0035] Note that the above are only preferred embodiments of the present invention and the technical principles used. Those skilled in the art will understand that the present invention is not limited to the specific embodiments described herein, and that various obvious changes, readjustments and substitutions can be made by those skilled in the art without departing from the scope of protection of the present invention. Therefore, although the present invention has been described in more detail through the above embodiments, the present invention is not limited to the above embodiments, and may include more other equivalent embodiments without departing from the concept of the present invention, and the scope of the present invention is determined by the scope of the appended claims.
Claims
1. A membraneless dialysis microfluidic control chip, characterized in that: include: A blood inlet (1), a dialysate inlet (2), a straight working flow channel (3), a reflective column (4), a curved working flow channel (5), a chip housing (6), a blood outlet (7) and a dialysate outlet (8); The blood inlet (1), the dialysate inlet (2), the straight working channel (3), the reflective column (4), the curved working channel (5), the blood outlet (7) and the dialysate outlet (8) are all installed in the chip housing (6); The blood inlet (1) and the dialysate inlet (2) are symmetrically installed at the inlet of the straight working flow channel (3); The blood outlet (7) and the dialysate outlet (8) are symmetrically installed at the outlet of the straight working flow channel (3); The straight working flow channel (3) and the arc-shaped working flow channel (5) are tangentially connected; The reflective columns (4) are respectively arranged in the straight working flow channel (3) and in the curved working flow channel (5); The reflective columns (4) have a diameter of 50-100 μm and a height of 200 μm; in the straight working channel (3), the spacing between the reflective columns (4) is 200-500 μm; in the curved working channel (5), the spacing between the reflective columns (4) is 150-300 μm.
2. The membraneless dialysis microfluidic control chip according to claim 1, characterized in that: The plurality of reflective columns (4) are arranged in sequence along a path formed by the straight working channel (3) and the curved working channel (5), and the radial distances from the center of each reflective column (4) arranged in the straight working channel (3) to the two sides of the straight working channel (3) are the same, and the radial distances from the center of each reflective column (4) arranged in the curved working channel (5) to the two sides of the curved working channel (5) are the same.
3. The membraneless dialysis microfluidic control chip according to claim 1, characterized in that: The angle between the blood inlet (1) and the dialysate inlet (2), and the angle between the blood outlet (7) and the dialysate outlet (8) are both 5°-30°.
4. The membraneless dialysis microfluidic control chip according to claim 1, characterized in that: The width of the blood inlet (1), the dialysate inlet (2), the blood outlet (7) and the dialysate outlet (8) are all 300-500 μm, and the height is all 200 μm.
5. The membraneless dialysis microfluidic control chip according to claim 1, characterized in that: The straight working channel (3) has a width of 400-600 μm and a height of 200 μm.
6. The membraneless dialysis microfluidic control chip according to claim 1, characterized in that: The arc-shaped working flow channel (5) has a curvature radius of 500-700 μm, a width of 400-600 μm, and a height of 200 μm.
